Last reviewed · How we verify
TD0069 hard capsule
TD0069 hard capsule is an investigational drug with unknown mechanism of action.
At a glance
| Generic name | TD0069 hard capsule |
|---|---|
| Also known as | Sunkovir |
| Sponsor | Sao Thai Duong Joint Stock Company |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Due to the lack of available information, the exact mechanism of action of TD0069 hard capsule is unknown.
Approved indications
Common side effects
Key clinical trials
- A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19 (PHASE3)
- Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |